Microbiome Sequencing Service Market, By Service Type (6S rRNA gene profiling, Whole genome shotgun sequencing, Targeted gene sequencing, Single-cell sequencing, and Others), By Application (Gut microbiome analysis, Urinary microbiome analysis, and Others

Global microbiome sequencing service market is estimated to be valued at USD 2.19 Bn in 2025 and is expected to exhibit a CAGR of 11.3% during the forecast period (2025-2032). Microbiome sequencing involves using high-throughput sequencing technologies to study the microbial communities within and associated with the human body. The human microbiome refers to the genomes of all microorganisms that reside on or within bodies. Advances in next-generation sequencing technologies have enabled the analysis of microbial communities at an unprecedented scale and resolution. Microbiome sequencing services provide genomic analysis of various microbial communities through targeted gene sequencing or whole metagenomic shotgun sequencing. This has transformed our understanding of the connections between the microbiome and various diseases, conditions, and drug responses in humans. By studying the complex microbial ecosystems in and on our bodies, we can gain valuable insights into human health and open up possibilities for novel diagnostics, prognostics, and therapeutics.

Market Dynamics

The global microbiome sequencing service market is driven by the rising adoption of microbiome analysis in various disease research and drug development activities. Microbiome research has shown links between gut microbes and various diseases like obesity, diabetes, cancer, and neurological and immune disorders. This is encouraging more investments by pharmaceutical and biotech firms into microbiome-based therapy development. However, the market potential is still restrained by the high costs associated with large-scale whole metagenomic shotgun sequencing services. Ongoing R&D into affordable sequencing techniques presents a major opportunity for market expansion. Growing application of microbiome profiling for developing personalized nutrition and probiotic-based products also present lucrative prospects. Partnerships between microbiome analysis firms and end-users are increasingly helping to tap new application segments.

Key Features of the Study

• This report provides an in-depth analysis of the global microbiome sequencing service market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global microbiome sequencing service market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes Microbiome Insights Inc., Baseclear B.V., Clinical Microbiomics A/S, Mérieux NutriSciences Corporation, MR DNA, Zymo Research Corporation, Metabiomics Corp., uBiome, Inc., Microbiome Therapeutics Innovation Group, Locus Biosciences, Inc., OpenBiome, Shanghai Ruiyi Biotechnology Co., Ltd., Resphera Biosciences, LLC, Molzym GmbH & Co. KG, BioSpherex LLC, and Diversigen.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global microbiome sequencing service market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global microbiome sequencing service market.

• Service Type Insights (Revenue, USD Bn, 2020 - 2032)
• 6S rRNA gene profiling
• Whole genome shotgun sequencing
• Targeted gene sequencing
• Single-cell sequencing
• Others
• Application Insights (Revenue, USD Bn, 2020 - 2032)
• Gut microbiome analysis
• Urinary microbiome analysis
• Others
• End User Insights (Revenue, USD Bn, 2020 - 2032)
• Academic and research institutes
• Pharmaceutical and Biotechnology companies
• Diagnostic laboratories
• Others
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa
• Key Players Insights
• Microbiome Insights Inc.
• Baseclear B.V.
• Clinical Microbiomics A/S
• Mérieux NutriSciences Corporation
• MR DNA
• Zymo Research Corporation
• Metabiomics Corp.
• uBiome, Inc.
• Microbiome Therapeutics Innovation Group
• Locus Biosciences, Inc.
• OpenBiome
• Shanghai Ruiyi Biotechnology Co., Ltd.
• Resphera Biosciences, LLC
• Molzym GmbH & Co. KG
• BioSpherex LLC